You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 8, August 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (60)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Oncology, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lymphatic Mapping and Focused Analysis of Sentinel Lymph Nodes Upstage Gastrointestinal Neoplasms

George J. Tsioulias, MD, DMSc; Thomas F. Wood, MD; Donald L. Morton, MD; Anton J. Bilchik, MD, PhD

Arch Surg. 2000;135:926-932.

Background  Lymph node analysis is essential for staging gastrointestinal (GI) neoplasms. Intraoperative lymphatic mapping and sentinel lymphadenectomy were originally described for melanoma but have not yet been investigated for most GI neoplasms.

Hypotheses  (1) Lymphatic mapping and sentinel lymphadenectomy is feasible in GI neoplasms, (2) the sentinel node (SN) status reflects the regional node status, and (3) focused analysis of the SN improves staging accuracy.

Design  Prospective patient series.

Patients and Methods  Lymphatic mapping was performed in 65 patients with GI neoplasms by injecting 0.5 to 1 mL of isosulfan blue dye around the periphery of the neoplasm. Blue-stained SNs were analyzed by hematoxylin-eosin staining, multiple sectioning, and cytokeratin immunohistochemistry.

Results  Lymphatic mapping identified at least 1 SN in 62 patients (95%). Of the 36 cases with nodal metastasis, 32 (89%) had at least 1 positive SN and 15 (42%) had nodal metastasis only in the SN. In 11 cases, tumor deposits were identified by multiple sectioning (n = 2) or immunohistochemistry (n = 9) only. In 5 cases (8%), lymphatic mapping identified aberrant lymphatic drainage that altered the extent of the lymphadenectomy.

Conclusions  Lymphatic mapping and sentinel lymphadenectomy are feasible in GI neoplasms and identify aberrant lymphatic drainage. The SN status accurately reflects the regional node status. Focused analysis of the SN increases the detection of micrometastases and may improve selection of patients for adjuvant treatment.


From the John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, Calif.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Surgery Reader's Choice: Continuing Medical Education
Arch Surg. 2000;135(8):992-993.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
Chen et al.
CA Cancer J Clin 2006;56:292-309.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Sampling and Analysis in Colon Cancer: What Is the Question?
Pocard et al.
JCO 2006;24:3712-3713.
FULL TEXT  

Prospective Multicenter Trial of Staging Adequacy in Colon Cancer: Preliminary Results
Bilchik et al.
Arch Surg 2006;141:527-534.
ABSTRACT | FULL TEXT  

1% Lymphazurin vs 10% Fluorescein for Sentinel Node Mapping in Colorectal Tumors
Dan et al.
Arch Surg 2004;139:1180-1184.
ABSTRACT | FULL TEXT  

Nodal staging of colorectal carcinomas and sentinel nodes
Cserni
J. Clin. Pathol. 2003;56:327-335.
ABSTRACT | FULL TEXT  

Molecular Lymphatic Mapping of the Sentinel Lymph Node
Taback et al.
Am. J. Pathol. 2002;161:1153-1161.
ABSTRACT | FULL TEXT  

Blue Urticaria: A Previously Unreported Adverse Event Associated With Isosulfan Blue
Sadiq et al.
Arch Surg 2001;136:1433-1435.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.